The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Canopy Biosciences, a Bruker Company, today announced the launch of a first in a series of assay kits for ChipCytometry TM, a quantitative, high dynamic range (HDR) and high-resolution multiplexing ...

G protein–coupled receptors (GPCRs) are one of the most popular target classes investigated in the drug-discovery process. With its selection of kits (cAMP femto, cAMP dynamic and cAMP HiRange), ...